Lv3
330 积分 2021-08-23 加入
Simulation of nitrosamine drug substance-related impurities from secondary amine-related impurities in approved human drug products
29天前
已完结
Regulatory and Ethical Frameworks for First-in-Human Clinical Trials in India: Proceedings of a Codesigned Capacity-Building Workshop
29天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
The Need for Clinical Trial Dataset Specifications to Support Clinical Pharmacology Review of Immunogenicity
2个月前
已完结
Analyses of U.S. FDA GCP Assessments and Recommendations for Marketing Applications, 2015–2024
2个月前
已完结
Advances and challenges for drug interaction evaluation - Perspectives on the ICH M12 guideline
2个月前
已完结
Technical challenges and quality considerations for dissolving microneedles
2个月前
已完结
Virtual Bioequivalence Assessment of Long-Acting Injectable Suspensions Using PBPK Modeling: Part 2. Type I Error and Safe Space Analyses
2个月前
已完结
Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability
2个月前
已完结
Lessons and Insights from a Case Study on Clinical Trial Fraud
2个月前
已完结
皖公网安备34019202002308
